Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Oramed Pharmaceuticals Inc. Board/Management Information 2017

Jul 23, 2017

6965_rns_2017-07-23_4cd7f8bb-145f-45bd-a7af-8684657d521f.htm

Board/Management Information

Open in viewer

Opens in your device viewer

_________ false

����� ����������� ���� 2 380
ORAMED PHARMACEUTICALS INC
Corporation no: 980376008 11653
- - -
Israel Securities Authority Tel Aviv Stock Exchange C002 ( Public ) Reported via MAGNA: 23/07/2017
www.isa.gov.il www.tase.co.il Reference: 2017-02-063316 Time of broadcast: 17:29 17:28:56

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onDeparture of the Chief Financial Officer and appointment of a new Chief Financial Officer

8K_CFO_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: -1 Date of revision of form structure: 16/07/2017
Address: Hi-tech Park, Givat Ram 2/4 p.o.b 39098 , Jerusalem 91390   , Israel Tel: 02-5660001 , 02-5788763 Fax: 02-5660004
E-mail address: [email protected]   Company site: www.ermed.com
Previous names of reporting entity:
Name of the Signatory: ZOMMER YIFAT HEN Position of Signatory in the reporting corporation: CFO & Secretary Name of Employer Company: .Oramed Ltd
Address: Hi-tech Park, Givat Ram 2/4 p.o.b 39098 , Jerusalem 91390 Telephone: 02-5788763 Facsimile: 02-5660004 E-mail: [email protected] 2
Israel